252 results on '"Das CJ"'
Search Results
2. Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies
- Author
-
Malaviya, AN, Shankar, S, Arya, V, Dhir, V, Agarwal, V, Pandya, S, Shanmuganandan, K, Chaturvedi, VP, and Das, CJ
- Published
- 2010
- Full Text
- View/download PDF
3. MRI in CNS lupus
- Author
-
Das, CJ, Jain, TP, and Seith, A
- Published
- 2008
- Full Text
- View/download PDF
4. Hepatic artery pseudoaneurysm secondary to an infected hydatid cyst and its management
- Author
-
Sharma S, Das Cj, Chumber S, and H A Venkatesh
- Subjects
medicine.medical_specialty ,Pseudoaneurysm ,medicine.anatomical_structure ,business.industry ,medicine ,Hydatid cyst ,General Medicine ,Radiology ,medicine.disease ,business ,Artery ,Surgery - Published
- 2016
- Full Text
- View/download PDF
5. Role of diffusion weighted imaging in diagnosis of post transplant lymphoproliferative disorders: Case reports and review of literature
- Author
-
Das, CJ, primary, Singh, A, additional, Gupta, AK, additional, and Bagchi, S, additional
- Published
- 2016
- Full Text
- View/download PDF
6. Imaging in bronchopulmonary sequestration
- Author
-
Abbey, P, primary, Das, CJ, additional, Pangtey, GS, additional, Seith, A, additional, Dutta, R, additional, and Kumar, A, additional
- Published
- 2009
- Full Text
- View/download PDF
7. Imaging of ascariasis
- Author
-
Das, CJ, primary, Kumar, J, additional, Debnath, J, additional, and Chaudhry, A, additional
- Published
- 2007
- Full Text
- View/download PDF
8. Solid pseudopapillary tumor of the pancreas with portal vein compression presenting as portal hypertension
- Author
-
Kandpal, H, primary, Sharma, R, additional, Das, CJ, additional, Sahni, P, additional, Das, AK, additional, and Neyaz, Z, additional
- Published
- 2007
- Full Text
- View/download PDF
9. Immune reconstitution inflammatory syndrome in a patient with cryptococcal lymphadenitis as the first presentation of acquired immunodeficiency syndrome
- Author
-
Sharma, SK, primary, Sinha, S, additional, Das, CJ, additional, and Tahir, M, additional
- Published
- 2007
- Full Text
- View/download PDF
10. Hepatobiliary and pancreatic: AIDS cholangiopathy
- Author
-
Das, CJ, primary and Sharma, R, additional
- Published
- 2006
- Full Text
- View/download PDF
11. Mature ovarian teratoma with gliomatosis peritonei - A case report
- Author
-
Sharma, R, primary, Thulkar, S, additional, Mukhopadhyay, S, additional, Deka, D, additional, Mannan, R, additional, and Das, CJ, additional
- Published
- 2005
- Full Text
- View/download PDF
12. Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.
- Author
-
Naswa N, Das CJ, Sharma P, Karunanithi S, Bal C, Kumar R, Naswa, Niraj, Das, Chandan Jyoti, Sharma, Punit, Karunanithi, Sellam, Bal, Chandrasekhar, and Kumar, Rakesh
- Abstract
Patients with multiple endocrine neoplasia type-1 syndromes are known to have neuroendocrine tumors (NETs) involving the pituitary and gastroenteropancreatic region, in addition to the presence of parathyroid abnormalities. In rare instances adenomas in the ectopic pituitary gland have been reported. As pituitary gland and pituitary adenomas are known to express SSTRs, somatostatin receptor scintigraphy can be used for imaging. Somatostatin receptor-based PET/CT imaging using 68Ga-DOTANOC has become a popular noninvasive imaging modality for evaluation of patients with NETs. The application of 68Ga-DOTANOC PET/CT can be extended to multiple endocrine neoplasia type 1 patients, as is evident from this case study. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
13. von Meyenburg's complex in a patient with primary malignancy: role of MRI.
- Author
-
Madhusudhan KS and Das CJ
- Abstract
von Meyenburg's complexes are benign liver malformations histologically constituting cystic dilatations of the bile ducts, surrounded by abundant fibrous stroma. Appearance of these lesions on MRI is characteristic and a fine needle aspiration or biopsy can be avoided and judicious management planned. We report a case of esophageal carcinoma who had suspicious lesions in the liver on CT scan, which after MRI were confi rmed as biliary hamartomas. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
14. Immune reconstitution inflammatory syndrome in a patient with cryptococcal lymphadenitis as the first presentation of acquired immunodeficiency syndrome.
- Author
-
Tahir M, Sharma SK, Sinha S, and Das CJ
- Abstract
Immune reconstitution inflammatory syndrome is commonly seen in acquired immunodeficiency syndrome (AIDS) patients having concomitant opportunistic infection, following initiation of highly active anti-retroviral therapy (HAART). We describe IRIS in a young man with unknown human immunodeficiency virus (HIV) status who presented with cryptococcal lymphadenitis as the first manifestation of AIDS. At presentation the patient had features overlapping with tuberculosis (TB) lymphadenitis which was ruled out by fine needle aspiration cytology. The patient responded to antifungal treatment but following the start of HAART, symptoms recurred which were managed conservatively. Though TB is common in India, a thorough workup including histopathology of lymph node should be done before the patient is started on anti-tuberculosis treatment. HIV infected patients having opportunistic co-infection should be closely monitored following initiation of HAART. [ABSTRACT FROM AUTHOR]
- Published
- 2007
15. Wandering dermoid-Report of a case.
- Author
-
Neyaz Z, Das CJ, Javan NG, and Vashisht S
- Published
- 2009
- Full Text
- View/download PDF
16. A 37-year-old married woman with 3-month history of galactorrhoea and irregular menstrual cycle. Diagnosis: multiple endocrine neoplasia type 1 (MEN 1), also known as Wermer's syndrome.
- Author
-
Das CJ, Debnath J, Javan N, Baruah MP, Das, Chandan Jyoti, Debnath, Jyotindu, Javan, N G, and Baruah, Manash Pratim
- Published
- 2007
17. Hepatic epithelioid hemangioendothelioma: a diagnostic pitfall in aspiration cytology.
- Author
-
Gupta R, Mathur SR, Gupta SD, Durgapal P, Iyer VK, Das CJ, Shalimar, and Acharya SK
- Abstract
Hepatic epithelioid hemangioendothelioma (EH) is a rare vascular neoplasm. An accurate radiologic diagnosis is usually dificult due to the presence of multiple nodules, simulating metastatic carcinoma. Though histologic features of this tumor are well described, cytologic reports of hepatic EH are very few in the available literature. We describe a case of a young healthy adult male who was found to have multiple hepatic masses on radiologic investigations. A guided ine needle aspiration demonstrated a poorly differentiated neoplasm. The diagnosis was made on core biopsy assisted by immunohistochemistry, which showed characteristic features of EH. He is doing well 14 months after diagnosis, without surgical excision or chemotherapy. An accurate diagnosis of hepatic EH on aspiration cytology requires an adequate specimen and awareness of its cytologic features, including discohesive atypical cells with intracytoplasmic lumina and intranuclear inclusions. Since this tumor is usually unresectable but has a favorable prognosis as compared to hepatocellular carcinoma, a correct diagnosis is essential for appropriate management and prognostication. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
18. Neurological picture. Dorsal intramedullary tuberculoma.
- Author
-
Tahir M, Das CJ, Ahmad FU, Ahmad H, Tahir, Mohammad, Das, Chandan Jyoti, Ahmad, Faiz U, and Ahmad, Hafeez
- Published
- 2007
- Full Text
- View/download PDF
19. Neurological picture. Ruptured intracranial dermoid.
- Author
-
Das CJ, Tahir M, Debnath J, Pangtey GS, Das, Chandan Jyoti, Tahir, Mohammad, Debnath, Jyotindu, and Pangtey, Ghan Shyam
- Published
- 2007
- Full Text
- View/download PDF
20. Neurological picture. Multiple ring enhancing lesions in brain MRI of a patient with AIDS.
- Author
-
Tahir M, Das CJ, Sharma SK, Sinha S, Singh UB, Tahir, Mohammad, Das, Chandan J, Sharma, S K, Sinha, Sanjeev, and Singh, U B
- Published
- 2007
21. Images in clinical medicine. Arterial microaneurysms in polyarteritis nodosa.
- Author
-
Das CJ, Pangtey GS, Das, Chandan Jyoti, and Pangtey, Ghan Shyam
- Published
- 2006
22. Preoperative embolisation of aneurysmal bone cyst of sternum.
- Author
-
Agarwal D, Sudhakaran D, Mohan A, and Das CJ
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2025
- Full Text
- View/download PDF
23. Can quantitative perfusion CT-based biomarkers predict renal cell carcinoma subtypes?
- Author
-
Sah A, Gupta A, Garg S, Yadav N, Khan MA, and Das CJ
- Abstract
Purpose: To assess diagnostic accuracy of perfusion CT (pCT) based biomarkers in differentiating clear-cell renal cell carcinoma (ccRCC) from non-ccRCC., Materials and Method: This retrospective study comprised 95 patients with RCCs (70 ccRCCs and 25 non-ccRCCs) who had perfusion CT (pCT) before surgery between January 2017 and December 2022. Two readers independently recorded PCT parameters [blood flow (BF), blood volume (BV), mean transit time (MTT), and time to peak (TTP)] by drawing a circular ROI on the tumor. The open-source program "Labelme" was used to create a polygonal bounding box to outline tumor borders. The intraclass correlation coefficient (ICC) was used to determine interreader agreement. The pCT model was evaluated using multivariable logistic regression analysis with the STATA 18 program to determine the importance of each of these characteristics in predicting the type of tumor., Results: Clear cell RCC had significantly greater MIP and lower TTP values than non-clear cell RCC (p < 0.05). RCCs showed considerably higher TTP, MTT, and lower MIP values than the normal renal cortex (p < 0.05). At a threshold of 129 HU, MIP had an AUC of 0.78, sensitivity and specificity of 80% and 70%, respectively, according to ROC analysis., Conclusions: pCT has a high diagnostic accuracy in distinguishing between ccRCC and non-ccRCC tumors; Clinical relevance: A non-invasive, accurate, reliable, and reproducible imaging biomarker for RCC subtype prediction is possible on pCT, which may be significant for evaluating the response to antiangiogenic therapy., Competing Interests: Declarations. Conflict of interest: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
24. Comparison of intravoxel incoherent motion and diffusion kurtosis imaging and 18- FDG PET/CT in response assessment in rectosigmoid carcinoma.
- Author
-
Chandola S, Soni A, Banerjee S, Bhattacharjee HK, Sharma R, Phulia A, Pathy S, and Das CJ
- Abstract
Objective: To evaluate the performance of intravoxel incoherent motion and diffusion kurtosis imaging (IVIM- DKI) in response assessment of rectosigmoid carcinoma to chemo-radiotherapy (CRT) and compare with 18-FDG PET/CT parameters., Methods: A total of 30 patients of recto-sigmoid cancer on CRT underwent baseline staging and follow-up with IVIM - DKI. Out of this cohort, 20 patients underwent 18-FDG PET/CT. IVIM- DKI MRI and PET/CT parameters were noted from both pre and post-chemoradiotherapy (done at 6 weeks after completion) scans. Quantitative IVIM-DKI parameters, viz. apparent (ADC) and molecular (D) diffusion coefficient, perfusion coefficient (f), and kurtosis (K) were measured from non-necrotic areas and semi-quantitative PET parameters including SUV max, SUV ratio, metabolic tumor volume (MTV), total lesion glycolysis (TLG) were also measured. All these parameters correlated with the patient's response keeping RECIST 1.1 criteria as reference standard., Results: A statistically significant increase in D and ADC with a significant decline in K was noted after therapy in the entire cohort. These changes were observed in both responders as well as non-responders. No significant differences were observed in the percentage changes of these parameters post therapy amongst both groups. Among 20 patients with follow-up PET/CT imaging, a significant decline in all parameters of primary lesion was seen post-therapy. Responders (n = 12) showed a significant decline in MTV and TLG from baseline after therapy, whereas non-responders did not show any such decline. Change in TLG (ɗ TLG), followed by ɗ MTV had the strongest correlation with a positive response. A ɗ TLG value of ≥ 54.19 carried a 79% sensitivity and 83% specificity in differentiating responders from non responders., Conclusion: 18-FDG PET/CT is a more accurate single modality for assessing both response and tumor burden post therapy, while ADC and D from IVIM MRI are useful adjuncts to response assessment., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
25. Quantitative magnetic resonance imaging in prostate cancer: A review of current technology.
- Author
-
Dhiman A, Kumar V, and Das CJ
- Abstract
Prostate cancer (PCa) imaging forms an important part of PCa clinical management. Magnetic resonance imaging is the modality of choice for prostate imaging. Most of the current imaging assessment is qualitative i.e. , based on visual inspection and thus subjected to inter-observer disagreement. Quantitative imaging is better than qualitative assessment as it is more objective, and standardized, thus improving interobserver agreement. Apart from detecting PCa, few quantitative parameters may have potential to predict disease aggressiveness, and thus can be used for prognosis and deciding the course of management. There are various magnetic resonance imaging-based quantitative parameters and few of them are already part of PIRADS v.2.1. However, there are many other parameters that are under study and need further validation by rigorous multicenter studies before recommending them for routine clinical practice. This review intends to discuss the existing quantitative methods, recent developments, and novel techniques in detail., Competing Interests: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article., (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
26. Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study.
- Author
-
Arulraj K, Sharma S, Das CJ, Seth A, and Kumar R
- Abstract
Introduction: Up to 40% of patients with suspected prostate cancer (PCa) have a negative prebiopsy magnetic resonance imaging (nMRI), and up to 15% of them may have clinically significant PCa (csPCa). The ability to predict the presence of csPCa despite nMRI may help avoid unnecessary biopsies. We aimed to determine the negative predictive value (NPV) of mpMRI, the influence of MRI reporting patterns in clinical practice, and the factors that might predict csPCa among men with an nMRI., Methodology: In an IRB-approved, ambispective study, men who underwent prostate biopsy from 2016 to 2023 and had a prebiopsy MRI, were included to determine the presence of csPCa. The reporting patterns of institutional and noninstitutional MRI were evaluated. Age, digital rectal examination (DRE) findings, prostate specific antigen (PSA), PSA density (PSAD), and MRI reports were evaluated for their ability to predict csPCa in men with nMRI., Results: 1660 patients who underwent prostate biopsy were assessed for eligibility, and 685 patients were enrolled in the study. The median age, PSA and PSAD were 60 years, 11.63 ng/ml and 0.23 ng/ml/cm
3 , respectively. 62 (9%) men had an nMRI, among which csPCa, non-csPCa, and negative biopsy were found in 34%, 5%, and 61% of men, respectively. 61% had an institutional MRI, while 39% had a noninstitutional MRI. The sensitivity and NPV of any MRI for csPCa were 93% and 66%, respectively, which improved to 96% and 81% for institutional MRI. Univariate and multivariate analyses showed abnormal DRE and PSAD ≥0.25 ng/ml/cc as predictive factors for csPCa in men with an nMRI., Conclusion: 34% of men with negative MRIs were found to harbor csPCa on prostate biopsy. The NPV of institutional MRI was higher than for noninstitutional MRI. Men with an abnormal DRE or PSAD ≥0.25 ng/ml/cc had a higher incidence of csPCa despite an nMRI., (© 2024 The Asian Pacific Prostate Society. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF
27. Intravoxel incoherent motion and diffusion kurtosis imaging and their machine-learning-based texture analysis for detection and assessment of prostate cancer severity at 3 T.
- Author
-
Das CJ, Malagi AV, Sharma R, Mehndiratta A, Kumar V, Khan MA, Seth A, Kaushal S, Nayak B, Kumar R, and Gupta AK
- Subjects
- Humans, Male, Aged, Middle Aged, Diffusion Magnetic Resonance Imaging, ROC Curve, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology, Machine Learning, Motion
- Abstract
Objectives: To evaluate the role of combined intravoxel incoherent motion and diffusion kurtosis imaging (IVIM-DKI) and their machine-learning-based texture analysis for the detection and assessment of severity in prostate cancer (PCa)., Materials and Methods: Eighty-eight patients underwent MRI on a 3 T scanner after giving informed consent. IVIM-DKI data were acquired using 13 b values (0-2000 s/mm
2 ) and analyzed using the IVIM-DKI model with the total variation (TV) method. PCa patients were categorized into two groups: clinically insignificant prostate cancer (CISPCa) (Gleason grade ≤ 6) and clinically significant prostate cancer (CSPCa) (Gleason grade ≥ 7). One-way analysis-of-variance, t test, and receiver operating characteristic analysis was performed to measure the discriminative ability to detect PCa using IVIM-DKI parameters. A chi-square test was used to select important texture features of apparent diffusion coefficient (ADC) and IVIM-DKI parameters. These selected texture features were used in an artificial neural network for PCa detection., Results: ADC and diffusion coefficient (D) were significantly lower (p < 0.001), and kurtosis (k) was significantly higher (p < 0.001), in PCa as compared with benign prostatic hyperplasia (BPH) and normal peripheral zone (PZ). ADC, D, and k showed high areas under the curves (AUCs) of 0.92, 0.89, and 0.88, respectively, in PCa detection. ADC and D were significantly lower (p < 0.05) as compared with CISPCa versus CSPCa. D for detecting CSPCa was high, with an AUC of 0.63. A negative correlation of ADC and D with GS (ADC, ρ = -0.33; D, ρ = -0.35, p < 0.05) and a positive correlation of k with GS (ρ = 0.22, p < 0.05) were observed. Combined IVIM-DKI texture showed high AUC of 0.83 for classification of PCa, BPH, and normal PZ., Conclusion: D, f, and k computed using the IVIM-DKI model with the TV method were able to differentiate PCa from BPH and normal PZ. Texture features of combined IVIM-DKI parameters showed high accuracy and AUC in PCa detection., (© 2024 John Wiley & Sons Ltd.)- Published
- 2024
- Full Text
- View/download PDF
28. Multimodality imaging of urinary tract tuberculosis.
- Author
-
Das CJ, Razik A, Tchoquessi RLN, Ramachandran A, Singh P, Rednam N, and Kundra V
- Abstract
Imaging is a key component of diagnosis and treatment response evaluation of urinary tract tuberculosis (UT TB). Tuberculosis can have a long latency, but if found early, one may have the opportunity to prevent complications such as ureteral strictures, obstructive nephropathy, contracted (thimble) bladder, renal parenchymal destruction/calcification, and renal failure. Imaging can aid in diagnosis and differential diagnoses, evaluate the extent of disease and complications, and guide image-directed biopsy, surgical planning, and evaluation of treatment response. Imaging abnormalities in the renal parenchyma and urinary tract at different stages of the disease, lymphadenopathy, and extra-urinary tract organ involvement are suggestive of UT TB. Recent advances in imaging modalities aid in UT TB diagnosis, follow-up, and guiding treatment., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
29. Quality of Life Determinants in Patients with Metastatic Prostate Cancer: Insights from a Cross-Sectional Questionnaire-Based Study.
- Author
-
Mittal C, Gupta H, Nagpal C, Sahoo RK, Sharma A, Gangadharaiah BB, Tansir G, Panaiyadiyan S, Shamim SA, Kaushal S, Das CJ, Haresh KP, Seth A, Nayak B, and Batra A
- Subjects
- Humans, Male, Cross-Sectional Studies, Surveys and Questionnaires, Aged, Middle Aged, Neoplasm Metastasis, Quality of Life, Prostatic Neoplasms psychology, Prostatic Neoplasms pathology, Prostatic Neoplasms drug therapy
- Abstract
Introduction: Prostate cancer is one of the most prevalent malignancies affecting men globally, with a significant impact on health-related quality of life (HRQOL). With the recent therapeutic advancements and improvements in survival, there is a need to understand the determinants of HRQOL in metastatic prostate cancer patients to optimize treatment strategies for quality of life as the number of survivors increases. The aim of this study was to identify clinical variables that affect HRQOL and its domains in patients with metastatic prostate cancer., Methods: We conducted a cross-sectional questionnaire-based study in patients diagnosed with metastatic prostate cancer at a tertiary cancer center in India. Baseline clinical features, treatment details, and completed Functional Assessment of Cancer Therapy-Prostate (FACT-P), composed of FACT-general (FACT-G) and prostate cancer-specific concerns subscale (PCS) and FACT-P Trial Outcome Index (FACT-P TOI) questionnaires, were collected. The mean total, as well as individual domain scores, were calculated. Additionally, these were stratified by the current treatment being received by patients. Linear regression was used to identify independent factors affecting HRQOL in these patients., Results: Of the 106 enrolled patients, 84 completed the FACT-P questionnaire and were included in the analysis. The median age was 66 years, and at the time of assessment, 3 patients (3.6%) were receiving androgen deprivation therapy only, 53 patients (63.1%) were on ADT + androgen receptor-targeted agents (ARTAs), and 18 patients (21.4%) patients received ADT + chemotherapy. The mean (±standard deviation) of the FACT-P TOI score was 70.33 (±15.16); the PCS subscale was the most affected, followed by functional well-being. Patients on chemotherapy scored significantly higher on PCS, but the composite scores were not significantly different. Univariable regression identified obesity (body mass index > 25 kg/m
2 ) and duration of first-line treatment as significant predictors of better HRQOL; however, obesity was the only independent predictor in multivariable analysis (β = 8.2; 95% confidence interval, 1.2 to 15.0; p = 0.022). Obesity also independently predicted a better FACT-P and its physical well-being domain score and PCS., Conclusion: Prostate cancer patients experience impaired QoL, especially in the prostate cancer-specific and functional well-being domains. Lower BMI is an independent predictor of poor QoL, and this requires efforts to assess the impact of strategies to manage the nutritional status of patients with metastatic disease on QoL outcomes.- Published
- 2024
- Full Text
- View/download PDF
30. Role of [18F]FDG-PET/CT in Evaluation of Tumor Response to Chemoradiation Therapy for Advanced Colorectal Cancer.
- Author
-
Soni A, Chandola S, Das CJ, Sharma R, Pathy S, Bhattacharjee HK, Chandrashekhara SH, Sharma A, and Kumar R
- Abstract
Objectives: The objective is to evaluate the efficacy of
18 F-fluorodeoxyglucose positron emission tomography (18 F-FDG-PET) computed tomography (CT) in the evaluation of tumor response to preoperative/palliative chemoradiotherapy (CRT) for advanced colorectal cancer; including metastatic cancer at primary presentation and recurrent cancers with local and/or distant metastasis., Materials and Methods: Fifty patients with advanced rectal cancer underwent two point imaging with 18 FDG PET-CT before and after 3 weeks of completion of preoperative/palliative CRT in between 2016 and 2022. Patients with locally recurrent cancer also underwent radical surgery. The assessment consisted of the evaluation of the following metabolic PET parameters: Maximum standardized uptake value (SUVmax ), SUVratio , metabolic tumor volume (MTV), and total lesion glycolysis (TLG). Response was assessed among the followed patients using RECIST 1.1 criteria., Observations and Results: There was a significant decline in the mean post therapy SUVmax and SUVratio as compared to baseline ( P = 0.0001). Twenty-six out of 50 (52%) patients were classified as responders. A significant decrease in all parameters (SUVmax , SUVratio , TLG, and MTV) from baseline was observed in responders of the study when comparing with nonresponders ( P < 0.05). Besides SUVmax and SUVratio , the mean posttherapy TLG was significantly reduced in responders than nonresponders ( P = 0.0065)., Conclusion: PET-CT is a useful combined anatomic and functional imaging modality in monitoring tumor response to preoperative/palliative CRT in advanced rectal cancer, whether primary or recurrent, including metastatic cancers at presentation. Posttherapy SUV and TLG in particular are significantly associated with treatment response., Competing Interests: There are no conflicts of interest., (Copyright: © 2024 Indian Journal of Nuclear Medicine.)- Published
- 2024
- Full Text
- View/download PDF
31. Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial.
- Author
-
Jain R, Kumar A, Sharma A, Sahoo RK, Sharma A, Seth A, Nayak B, Shamim SA, Kaushal S, Kp H, Das CJ, and Batra A
- Abstract
Background: Approximately 20%-25% of patients with metastatic castration-resistant prostate cancer (mCRPC) harbor a deleterious germline or somatic mutation in the homologous recombination repair (HRR) pathway genes, which is involved in the repair of double-stranded DNA damage. Half of these mutations are germline, while the remaining are exclusively somatic. While polyadenosine 5'diphosphoribose [poly (ADP-ribose)] polymerase inhibitors, such as olaparib and rucaparib, are effective in this subgroup, their widespread use is limited due to the associated high cost, especially in resource-constrained settings. Notably, platinum agents like carboplatin have exquisite sensitivity to cells with defective DNA repair machinery. Carboplatin, a conventional, inexpensive chemotherapeutic agent, offers a potential alternative treatment in such patients. Several retrospective small case series support this hypothesis. However, there are no prospective clinical trials of carboplatin in patients with mCRPC with HRR mutations., Objective: The primary objective is to assess the objective response rate of 3 weekly carboplatin treatments in patients with mCRPC harboring deleterious mutations in the HRR pathway genes and previously treated with a taxane or a novel antiandrogen agent. The secondary objectives include progression-free survival, health-related quality of life, and safety profile of carboplatin., Methods: Patients diagnosed with mCRPC harboring HRR pathway mutations previously treated with docetaxel or novel antiandrogen agents (abiraterone, enzalutamide, apalutamide, or darolutamide) or both will be eligible. Genes involved directly or indirectly in the HRR pathway will be tested. In this single-arm phase II study, we will screen approximately 200 patients to enroll 49 patients, and carboplatin (dosing at the area under curve=5) will be administered every 3 weeks until progression or intolerable side effects. The primary end point will be assessed as the proportion of patients with a reduction of serum prostate-specific antigen by more than 50% from enrollment. Secondary outcomes include progression-free survival-soft-tissue disease progression (by response evaluation criteria in solid tumors, version 1.1, and bone lesion progression using Prostate Cancer Clinical Trials Working Group 3 criteria), health-related quality of life during carboplatin treatment using the Functional Assessment of Cancer Therapy-Prostate questionnaire and the European Organisation for Research and Treatment of Cancer questionnaire and safety profile of carboplatin (National Cancer Institute's Common Terminology Criteria for Adverse Events version 5.0)., Results: The trial started enrollment in September 2023. This trial is ongoing, and 12 patients have been recruited to date. All 49 participants will be enrolled according to plan., Conclusions: This prospective phase II trial represents a critical step toward addressing the therapeutic gap in patients with mCRPC harboring HRR pathway mutations, particularly in demographic regions with limited access to poly (ADP-ribose) polymerase inhibitors. Outcomes from this study will inform clinical practice and guide future phase III randomized trials, ultimately improving patient outcomes globally., Trial Registration: Clinical Trials Registry of India CTRI/2023/04/051507; https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=Njc0NjU=&Enc=&userName=., International Registered Report Identifier (irrid): DERR1-10.2196/54086., (©Rishabh Jain, Akash Kumar, Atul Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim A Shamim, Seema Kaushal, Haresh KP, Chandan J Das, Atul Batra. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 18.04.2024.)
- Published
- 2024
- Full Text
- View/download PDF
32. Exploring the Labyrinth: Imaging in Systemic Vasculitis.
- Author
-
Kaur T, Pangtey GS, Vyas S, Chaudhury H, Illur AV, and Das CJ
- Subjects
- Humans, SARS-CoV-2, COVID-19 complications, Systemic Vasculitis diagnostic imaging, Systemic Vasculitis diagnosis
- Abstract
Systemic vasculitis is an immune-mediated group of disorders broadly classified based on the involved vessel type. It has myriad clinical presentations, adding to the challenge of timely diagnosis and management. Thus, imaging has taken center stage in the diagnosis of these disorders as there is a lack of definitive clinical diagnostic markers. Various available imaging modalities can be used for diagnosis and follow-up on these patients. The coronavirus disease 2019 (COVID-19) has added a new dimension to the already existing problem of vasculitis. The virus has shown great affinity for the vascular endothelium, leading to multisystem organ vasculitis. There has been a spike in vasculitis cases in the COVID-19 pandemic era, thus necessitating more research and studies in this field for a better understanding of the disease. In this review, we wish to summarize the various imaging spectrums of classical systemic vasculitis along with the new addition of COVID-19-related vasculitis to the already long list., (© Journal of the Association of Physicians of India 2024.)
- Published
- 2024
- Full Text
- View/download PDF
33. Combined endovascular and percutaneous approach to the management of spontaneous splenic arteriovenous fistula.
- Author
-
Das CJ, Selvaraju A, Aggarwal P, and Chumber S
- Subjects
- Female, Humans, Portal Vein, Arteriovenous Fistula, Splenic Diseases, Abdominal Cavity
- Abstract
A splenic arteriovenous fistula (AVF) is an uncommon splenic vascular disease which can be congenital or acquired. A 40yr old woman, without any history of chronic liver disease, presented with non-specific pain abdomen, underwent contrast-enhanced CT and was diagnosed to have a splenic AVF with multiple intervening venous aneurysms and early filling of the portal vein. The vascular abnormality was successfully treated with a combined percutaneous glue embolisation and endovascular balloon-assisted coil embolisation. Neither recurrence nor other complications were observed in the patient during the follow-up after 6 months., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
34. Role of non-contrast CT component of prostate-specific membrane antigen PET/CT scan in the detection of peripheral zone prostate cancer.
- Author
-
Aggarwal P, Krishna Kumar RG, Das CJ, Kubihal V, Subudhi TK, Khan MA, and Kumar R
- Subjects
- Adult, Humans, Male, Prostate, Retrospective Studies, Tomography, X-Ray Computed, Positron Emission Tomography Computed Tomography, Prostatic Neoplasms
- Abstract
Objective: The aim of this study was to look for feasibility of non-contrast CT (NCCT) in detecting peripheral zone prostate cancer (PCa)., Methods: A retrospective analysis included 50 biopsy-proven PCa patients between April 2019 and March 2022 who underwent staging whole body prostate-specific membrane antigen (PSMA)/CT prior to treatment. The control subjects were 50 randomly selected adult male patients who underwent PET/CT for non-prostate malignancy during the same time period. Two readers independently calculated the Hounsfield unit (HU) of normal peripheral zone, central zone, and corresponding PSMA avid focus in cases., Results: No significant difference was seen in the mean HU value of normal peripheral zone between cases and controls. Significant difference in the mean HU was seen between the PSMA avid focus in cases (40.1 ± 6.2) and normal peripheral zone of cases (28.2 ± 7.0) and controls (27.7 ± 5.8). No significant difference was found between the mean HU values of high-grade PCa and non-high-grade PCa. Receiver operating characteristic (ROC) curve analysis revealed a mean HU cut-off of ≥35 for detecting PCa with a sensitivity and specificity of 86% and 90%, respectively, between cases and controls (AUC 0.88)., Conclusion: Detection of clinically significant PCa is possible on routinely performed NCCT scans. Radiologists should routinely look for and convey these findings to facilitate further work-up and early detection of PCa., Advances in Knowledge: Our study adds to the knowledge that NCCT scans performed for unrelated indications can serve as a screening tool for clinically significant PCa., (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Institute of Radiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
35. Role of high-dose methylprednisolone in Zargar Grade IIB corrosive esophageal burns: A randomized control study.
- Author
-
Sheikh I, Jamshed N, Neseem A, Aggarwal P, Kedia S, Khan MA, Das CJ, and Sahu AK
- Abstract
Objective: The objective of the study is to test the efficacy of high-dose methylprednisolone in the prevention of esophageal stricture after corrosive ingestion., Methods: This study was a single-center, randomized controlled single-blinded study. Simple randomization was done with 15 adult patients (>18 years) in each arm, who presented with a history of corrosive ingestion within the past 24 h and had esophageal injury of Zargar Grade IIB on endoscopy. Intravenous methylprednisolone 1 g/day for 3 days was given to the intervention arm while 100 mL of normal saline was given as placebo in control arm. Follow-up to diagnose esophageal stricture was done at 8 weeks., Results: Thirty patients (15 in each arm) were recruited for the study. As per the intention to treat analysis, 33% and 46.6% developed stricture in the intervention and control arm, respectively (relative risk [RR] = 0.714; 95% confidence interval 0.29-1.75; P = 0.462). 40% patients in control group and 7.7% in intervention group had undergone feeding jejunostomy, which was statistically significant with a p-value of 0.048. Airway injury showed significant clinical improvement in the intervention arm but the difference was nonsignificant statistically ( P = 0.674). There was no increased incidence of hypertension, hyperglycemia, hyponatremia, hyperkalemia, or infections in intervention arm., Conclusion: Methylprednisolone does not help in the prevention of stricture formation in corrosive esophageal injury, but it significantly reduces the requirement of feeding jejunostomy and has a beneficial role in treating airway injury., Competing Interests: None Declared., (Copyright: © 2024 Turkish Journal of Emergency Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
36. Role of Contrast-Enhanced Ultrasound in Evaluation of Cystic Renal Mass.
- Author
-
Das CJ, Agarwal K, Sharma S, and Seth A
- Subjects
- Humans, Tomography, X-Ray Computed methods, Kidney diagnostic imaging, Predictive Value of Tests, Ultrasonography methods, Contrast Media, Kidney Neoplasms diagnostic imaging
- Abstract
Objectives: Contrast-enhanced ultrasound (CEUS) allows excellent delineation of perfusion in septa and nodules without exposure to ionizing radiation or nephrotoxic contrast media. The aim of our study was to evaluate the role of CEUS for the assessment of cystic renal masses and compare its diagnostic performance with that of CECT., Methods: Exactly 40 patients diagnosed to have cystic renal masses on CECT scan were prospectively evaluated with CEUS and were assigned a Bosniak class. Based on results of final histopathology and clinical follow-up, internal validity of both CEUS and CECT was evaluated, including agreement between these two modalities., Results: Out of the 40 patients (mean size 3.1 ± 2.5 cm), 23 patients had benign lesions and 17 patients had malignant lesions. For CEUS, the sensitivity and negative predictive value was 100%, the specificity and positive predictive value was 73.9%. For CECT, the sensitivity and negative predictive value were 88.2 and 83.3%, respectively, whereas the specificity and positive predictive value was 87 and 90.9%, respectively. Both imaging modalities had similar accuracy with fair to good agreement with the final diagnosis (Κ = 0.71 and 0.75 for CEUS and CECT, respectively). Concordance between CEUS and CECT was seen in 29 patients (72.5%) with fair agreement between the two modalities (K = 0.66)., Conclusion: CEUS has comparable accuracy with CECT and could be used as screening modality to rule out the presence of complex cystic renal masses without exposure of nephrotoxic contrast media and ionizing radiation., (© 2023 American Institute of Ultrasound in Medicine.)
- Published
- 2023
- Full Text
- View/download PDF
37. Assessment of CT perfusion indices of the clinicoradiological response to anti-tubercular therapy in patients with intestinal tuberculosis.
- Author
-
Sasi A, Ahuja V, Das CJ, Arora U, Garg P, Razik A, Kedia S, Das P, Jadon RS, Soneja M, and Wig N
- Subjects
- Adult, Female, Humans, Prospective Studies, Male, Peritonitis, Tuberculous, Tomography, X-Ray Computed methods
- Abstract
Aim: To explore the possibility of using a novel technique, CT perfusion imaging, to monitor the response to anti-tubercular therapy (ATT) in patients with intestinal tuberculosis., Materials and Methods: A prospective observational study was performed in adults with treatment naive-intestinal tuberculosis. Clinical, endoscopic, and conventional radiological findings of patients were compared at baseline and post-ATT. CT perfusion imaging was performed with recording of six perfusion parameters (blood flow, blood volume, mean transit time, time to peak, maximum peak intensity, and permeability/blood flow extraction)., Results: Twenty-two patients (13 women, 59%) with a median age of 25 years were recruited. The terminal ileum and ileocaecal junction were the most frequent sites of involvement (59%), with multiple segments of the intestine being involved in 16 patients (73%). Median duration of ATT was 6 months (range 6-10 months). Complete clinical response was observed in 22/22 (100%) patients, endoscopic response in 12/12 (100%) patients, and radiological response in 10/13 (76%) patients. There was a significant decrease in mean blood flow, blood volume, maximum peak intensity, and an increase in mean transit time and time to peak on follow-up CT perfusion imaging performed after 6 months of ATT., Conclusion: Significant alterations in CT perfusion parameters were demonstrated following treatment, consistent with a decline in inflammation and vascularity. CT perfusion imaging of the bowel is a novel means to assess the radiological response to ATT in intestinal tuberculosis, although at the cost of a higher dose of radiation exposure., (Copyright © 2023. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
38. Abdominal visceral tuberculosis: a malignancy mimic.
- Author
-
Das CJ, Rednam N, Vora Z, Aggarwal A, Chandrashekhara SH, and Kundra V
- Subjects
- Humans, Abdomen diagnostic imaging, Abdomen pathology, Biopsy, Peritonitis, Tuberculous diagnostic imaging, Tuberculosis, Gastrointestinal diagnostic imaging, Neoplasms
- Abstract
The purpose is to discuss abdominal tuberculosis mimicking malignancy involving the abdominal viscera. TB of the abdominal viscera is common, especially in countries where tuberculosis is endemic and in pockets of non-endemic countries. Diagnosis is challenging as clinical presentations are often non-specific. Tissue sampling may be necessary for definitive diagnosis. Awareness of the early and late disease imaging appearances of abdominal tuberculosis involving the viscera that can mimic malignancy can aid detecting TB, providing a differential diagnosis, assessing extent of spread, guiding biopsy, and evaluating response., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
39. A rare diagnosis of renal replacement lipomatosis.
- Author
-
Dasgupta R, Das CJ, and Gupta A
- Abstract
Renal replacement lipomatosis (RRL) is a rare, benign entity characterized by marked fat proliferation within the renal sinus and perinephric space. We present images of a patient with RRL., Competing Interests: Conflicts of interest: There are no conflicts of interest., (Copyright: © 2023 Indian Journal of Urology.)
- Published
- 2023
- Full Text
- View/download PDF
40. Determination of the optimal length of insertion for central venous catheterization via axillary vein cannulation using preoperative chest X-ray- A prospective feasibility study.
- Author
-
Naik S, Pappu A, Sarathkumar MS, Ramachandran R, Arora MK, Trikha A, Singh PM, Anand RK, Das CJ, and Rewari V
- Abstract
Background and Aims: Ensuring safe central venous catheter tip placement is important. Multiple techniques are available to estimate the length of catheter insertion for subclavian and internal jugular approaches. However, the methods to determine the length of insertion for the axillary route have not been validated. The purpose of this feasibility study was to evaluate a simple method for the calculation of catheter length to be inserted and assess whether it accurately predicts the correct tip placement., Material and Methods: A total of 102 patients requiring preoperative central venous cannulation were evaluated, out of which 60 had successful axillary vein (AxV) cannulation. The length of insertion was calculated using the formula: (2/3* A + B) +Y (A: Clavicular length on chest radiograph [CXR], B: Vertical distance between the sternal head and carina on CXR, Y: Perpendicular distance from the skin to the AxV on ultrasound). A postoperative CXR was used to assess the accurate tip placement (2 cm above the carina to 0.5 cm below it). The primary outcome of the study was the rate of successful placement of the central venous catheter (CVC) in terms of the correct position of the tip of the catheter when the length of the catheter inserted was predicted by the formula described previously., Results: Optimal placement was observed in 83.33% of the cases. A higher rate of accuracy was seen in the females ( P value = 0.03) and shorter patients ( P value = 0.01). A Bland-Altman plot depicted a high degree of agreement., Conclusion: Use of the formula using a CXR and ultrasound allowed P successful placement of the CVC tip at the desired location in 83.33% of the cases., Competing Interests: There are no conflicts of interest., (Copyright: © 2023 Journal of Anaesthesiology Clinical Pharmacology.)
- Published
- 2023
- Full Text
- View/download PDF
41. Assessment of renal allograft rejection with diffusion tensor imaging.
- Author
-
Das CJ, Kubihal V, Kumar S, Agarwal SK, Dinda AK, and Sreenivas V
- Subjects
- Humans, Prospective Studies, Kidney pathology, Diffusion Magnetic Resonance Imaging methods, Anisotropy, Allografts diagnostic imaging, Diffusion Tensor Imaging methods, Kidney Transplantation
- Abstract
Objectives: To investigate the value of DTI in differentiation of renal allograft rejection from well-functioning stable allograft, using fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values., Methods: In this prospective study, 22 transplant recipients with well-functioning stable allograft (group A) and 20 patients with renal allograft rejection (group B + C) were recruited over a period of 19 months from January 2018 to July 2019. DTI-MRI was performed in all the patients, and FA and ADC values were measured in cortical and medullary regions of the transplanted kidney. On biopsy, graft rejection was classified as acute (group B) ( n = 7) and chronic graft rejection (group C) ( n = 13) based on the BANNF scoring system. Statistical analysis was performed using STATA v.14.0., Results: Statistically significant difference between group A and group B + C was noted for cortical ( p < 0.001), and medullary ( p = 0.003) FA values, and cortical ( p = 0.020), and medullary ( p = 0.046) ADC values. Cortical( p < 0.001) and Medullary( p = 0.020) FA values showed statistically significant difference between group A and group C, and cortical FA value( p = 0.012) also showed statistically significant difference between group B and group C. AUC (to differentiate between renal allograft rejection and well-functioning stable allograft) for cortical, and medullary FA values and cortical and medullary ADC values were 0.853( p < 0.001), 0.757( p = 0.004), 0.709( p = 0.021) and 0.736( p = 0.009), respectively., Conclusion and Advances in Knowledge: DTI is a promising functional MRI technique for the non-invasive assessment of renal allograft function. Diffusion parameters, such as FA and ADC values, can be useful in the differentiation of renal allograft rejection from well-functioning stable allograft.
- Published
- 2023
- Full Text
- View/download PDF
42. The Role of Triple Rule-out CT in an Indian Emergency Setting.
- Author
-
Pattereth N, Chaliyadan S, Mathew R, Kumar S, Das CJ, Aggarwal P, and Jamshed N
- Abstract
Background: Emergency physicians are acutely aware of the consequences of missing fatal diagnoses for acute non-traumatic chest pain and subjecting patients to over-testing. In the large arsenal of tests that are available to us, a triple rule-out computed tomography (TRO-CT) Angiography is often less pursued, due to concerns about their efficacy and safety or because of nescience. We aim to find the yield of the test in an Indian emergency setting and impart some knowledge about it along the way., Materials and Methods: Twenty-six patients who presented to the emergency department of our institute with acute chest pain, with non-specific electrocardiogram (ECG) findings and negative serial troponin I, underwent TRO-CT. HEART scores of all patients, calculated at their presentation, were correlated with TRO-CT findings., Results: Triple rule-out computed tomography angiography was positive in 5 patients (20%), of which 4 cases (16%) were diagnosed to have significant coronary artery disease and one had an acute pulmonary embolism. All 4 patients who had significant coronary artery disease (CAD) diagnosed by TRO-CT had a HEART score of intermediate risk. The mean effective radiation dose of the entire TRO study was 19.024 ± 3.319 mSv (range = 13.89-25.95 mSv)., Conclusion: Triple rule-out CT angiography is a useful tool in the evaluation of patients presenting with acute chest pain in the emergency and can be an important adjunct in ruling out significant CAD in intermediate-risk patients. Emergency physicians and young residents need to know about this tool in their armamentarium to tackle doubtful cases., How to Cite This Article: Pattereth N, Chaliyadan S, Mathew R, Kumar S, Das CJ, Aggarwal P. et al. The Role of Triple Rule-out CT in an Indian Emergency Setting. Indian J Crit Care Med 2023;27(3):190-194., Competing Interests: Source of support: Nil Conflict of interest: None, (Copyright © 2023; The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
43. Postdialysis catheter insertion femoral arteriovenous fistula: A novel approach to endovascular management.
- Author
-
Bhalla D, Hemachandran N, Wani GM, Agarwal SK, and Das CJ
- Subjects
- Humans, Renal Dialysis, Catheterization, Catheters, Femoral Artery diagnostic imaging, Arteriovenous Fistula, Endovascular Procedures
- Published
- 2023
- Full Text
- View/download PDF
44. Quantification of prostate tumour diameter and volume from MR images using 3D ellipsoid model and its impact on PI-RADS v2.1 assessment.
- Author
-
Singh D, Das CJ, Kumar V, Singh A, and Mehndiratta A
- Subjects
- Male, Humans, Prostate-Specific Antigen, Magnetic Resonance Imaging methods, Retrospective Studies, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology
- Abstract
Maximum diameter and volume of the tumour provide important clinical information and are decision-making parameters for patients suspected with prostate cancer (PCa). The objectives of this study were to develop an automated method for 3D tumour measurement and compare it with the radiologist's manual assessment, as well as to investigate the impact of 3D tumour measurement on Prostate Imaging-Reporting and Data System version-2.1 (PI-RADS v2.1) scoring of prostate cancer. Tumour maximum diameter and volume were calculated using automated ellipsoid-fit method. For all PI-RADS scores, mean ± standard deviation range of tumour maximum diameter and volume measured using ellipsoid-fit method were 1.36 ± 0.28 to 1.97 ± 0.67 cm and 0.49 ± 0.31 to 1.05 ± 0.78 cc and manual assessment were in range of 0.73 ± 0.12 to 1.14 ± 0.25 cm and 0.36 ± 0.21 to 0.93 ± 0.39 cc, respectively. Ellipsoid-fit method showed significantly (p < 0.05) higher values for maximum diameter and volume than manual assessment. 3D measurement of tumour using ellipsoid-fit method was found to have higher maximum diameter and volume values (in 40-61% patients) compared to conventional assessment by radiologist, which may have an impact on PI-RADS v2.1 scoring system., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
45. Morrison's Pouch: Anatomy and Radiological Appearance of Pathological Processes.
- Author
-
Kaur G, Kaur T, and Das CJ
- Abstract
Morrison's pouch is the intraperitoneal space in the supramesocolic compartment located between the right liver lobe and right kidney. Pathological conditions that can involve this peritoneal space include fluid collections, infectious or inflammatory processes, and neoplasms. Frequent involvement by disease entities can be attributed to its dependent location, communication with the inframesocolic compartment, close proximity to the adjacent organs and peritoneal fluid dynamics. Knowledge of the appearance of pathological entities on various imaging modalities helps the radiologist in making the correct diagnosis., Competing Interests: Conflict of Interest None declared., (Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).)
- Published
- 2022
- Full Text
- View/download PDF
46. Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer.
- Author
-
Singh D, Kumar V, Das CJ, Singh A, and Mehndiratta A
- Abstract
Background: Prostate Imaging-Reporting and Data System version 2.1 (PI-RADS v2.1) was developed to standardize the interpretation of multiparametric MRI (mpMRI) for prostate cancer (PCa) detection. However, a significant inter-reader variability among radiologists has been found in the PI-RADS assessment. The purpose of this study was to evaluate the diagnostic performance of an in-house developed semi-automated model for PI-RADS v2.1 scoring using machine learning methods., Methods: The study cohort included an MRI dataset of 59 patients (PI-RADS v2.1 score 2 = 18, score 3 = 10, score 4 = 16, and score 5 = 15). The proposed semi-automated model involved prostate gland and zonal segmentation, 3D co-registration, lesion region of interest marking, and lesion measurement. PI-RADS v2.1 scores were assessed based on lesion measurements and compared with the radiologist PI-RADS assessment. Machine learning methods were used to evaluate the diagnostic accuracy of the proposed model by classification of PI-RADS v2.1 scores., Results: The semi-automated PI-RADS assessment based on the proposed model correctly classified 50 out of 59 patients and showed a significant correlation ( r = 0.94, p < 0.05) with the radiologist assessment. The proposed model achieved an accuracy of 88.00% ± 0.98% and an area under the receiver-operating characteristic curve (AUC) of 0.94 for score 2 vs. score 3 vs. score 4 vs. score 5 classification and accuracy of 93.20 ± 2.10% and AUC of 0.99 for low score vs. high score classification using fivefold cross-validation., Conclusion: The proposed semi-automated PI-RADS v2.1 assessment system could minimize the inter-reader variability among radiologists and improve the objectivity of scoring., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Singh, Kumar, Das, Singh and Mehndiratta.)
- Published
- 2022
- Full Text
- View/download PDF
47. Imaging of hydatid cyst of kidney, ureter and urinary bladder.
- Author
-
Gupta S and Das CJ
- Subjects
- Diagnosis, Differential, Humans, Kidney diagnostic imaging, Kidney pathology, Tomography, X-Ray Computed, Urinary Bladder diagnostic imaging, Urinary Bladder pathology, Echinococcosis diagnostic imaging, Echinococcosis pathology, Kidney Diseases diagnosis, Ureter diagnostic imaging
- Abstract
Renal hydatid is an uncommon finding, reported in less than 5% patients with hydatid infection. Hydatid involvement of ureter and urinary bladder is an even rarer entity. Renal hydatid is typically unilateral, solitary and arises from cortex. It is essential to be aware of the imaging features of the hydatid cyst for proper diagnosis. Knowledge of the imaging features of various stages is essential since treatment decision is based on cyst stage. Hydatid cyst can mimic several entities both benign and malignant. We present a pictorial review to illustrate the radiological imaging features of hydatid disease involving kidney, ureter and bladder region and its complications.
- Published
- 2022
- Full Text
- View/download PDF
48. Non-Invasive characterisation of renal stones using dual energy CT: A method to differentiate calcium stones.
- Author
-
Bharati A, Rani Mandal S, Gupta AK, Seth A, Sharma R, Bhalla AS, Das CJ, Chatterjee S, and Kumar P
- Subjects
- Calcium Oxalate, Humans, Kidney, Tomography, X-Ray Computed methods, Calcium, Kidney Calculi diagnostic imaging
- Abstract
Background: Non-invasive DECT based characterization of renal stones using their effective atomic number (Z
eff ) and the electron density (ρe) in patients., Aim: This paper aims to develop a method for in-vivo characterization of renal stone. Differentiation of renal stones in-vivo especially sub types of calcium stones have very important advantage for better judgement of treatment modality., Materials and Methods: 50 extracted renal stones were scanned ex-vivo using dual energy CT scanner. A method was developed to characterize these renal stones using effective atomic number and electron density obtained from dual energy CT data. The method and formulation developed in ex-vivo experiments was applied in in-vivo study of 50 randomly selected patients of renal stones who underwent dual energy CT scan., Results: The developed method was able to characterize Calcium Oxalate Monohydrate (COM) and the combination of COM and Calcium Oxalate Dihydrate (COD) stones non-invasively in patients with a sensitivity of 81% and 83%respectively. The method was also capable of differentiating Uric, Cystine and mixed stones with the sensitivity of 100, 100 and 85.71% respectively., Conclusion: The developed dual energy CT based method was capable of differentiating sub types of calcium stones which is not differentiable on single energy or dual energy CT images., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
49. IVIM-DKI for differentiation between prostate cancer and benign prostatic hyperplasia: comparison of 1.5 T vs. 3 T MRI.
- Author
-
Malagi AV, Netaji A, Kumar V, Baidya Kayal E, Khare K, Das CJ, Calamante F, and Mehndiratta A
- Subjects
- Humans, Male, Motion, Reproducibility of Results, Diffusion Tensor Imaging methods, Prostatic Hyperplasia diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology
- Abstract
Objective: To implement an advanced spatial penalty-based reconstruction to constrain the intravoxel incoherent motion (IVIM)-diffusion kurtosis imaging (DKI) model and investigate whether it provides a suitable alternative at 1.5 T to the traditional IVIM-DKI model at 3 T for clinical characterization of prostate cancer (PCa) and benign prostatic hyperplasia (BPH)., Materials and Methods: Thirty-two patients with biopsy-proven PCa were recruited for MRI examination (n = 16 scanned at 1.5 T, n = 16 scanned at 3 T). Diffusion-weighted imaging (DWI) with 13 b values (b = 0 to 2000 s/mm
2 up to 3 averages, 1.5 T: TR = 5.774 s, TE = 81 ms and 3 T: TR = 4.899 s, TE = 100 ms), T2-weighted, and T1-weighted imaging were used on the 1.5 T and 3 T MRI scanner, respectively. The IVIM-DKI signal was modeled using the traditional IVIM-DKI model and a novel model in which the total variation (TV) penalty function was combined with the traditional model to optimize non-physiological variations. Paired and unpaired t-tests were used to compare intra-scanner and scanner group differences in IVIM-DKI parameters obtained using the novel and the traditional models. Analysis of variance with post hoc test and receiver operating characteristic (ROC) curve analysis were used to assess the ability of parameters obtained using the novel model (at 1.5 T) and the traditional model (at 3 T) to characterize prostate lesions., Results: IVIM-DKI modeled using novel model with TV spatial penalty function at 1.5 T, produced parameter maps with 50-78% lower coefficient of variation (CV) than traditional model at 3 T. Novel model estimated higher D with lower D*, f and k values at both field strengths compared to traditional model. For scanner differences, the novel model at 1.5 T estimated lower D* and f values as compared to traditional model at 3 T. At 1.5 T, D and f values were significantly lower with k values significantly higher in tumor than BPH and healthy tissue. D (AUC: 0.98), f (AUC: 0.82), and k (AUC: 0.91) parameters estimated using novel model showed high diagnostic performance in cancer lesion detection at 1.5 T., Discussion: In comparison with the IVIM-DKI model at 3 T, IVIM-DKI signal modeled with the TV penalty function at 1.5 T showed lower estimation errors. The proposed novel model can be utilized for improved detection of prostate lesions., (© 2021. European Society for Magnetic Resonance in Medicine and Biology (ESMRMB).)- Published
- 2022
- Full Text
- View/download PDF
50. Imaging Spectrum of Female Genital Tuberculosis: A Comprehensive Review.
- Author
-
Aggarwal A, Das CJ, and Manchanda S
- Subjects
- Fallopian Tubes pathology, Female, Humans, Ovary pathology, Pregnancy, Uterus pathology, Infertility, Female microbiology, Infertility, Female pathology, Tuberculosis, Female Genital complications, Tuberculosis, Female Genital diagnostic imaging
- Abstract
Female genital tuberculosis is a relatively uncommon form of extrapulmonary tuberculosis that is under-reported and under-recognized. The early course of the disease has fewer manifestations, resulting in late presentation with grave complications like infertility and ectopic pregnancy. Also, difficulty in isolation of the causative bacteria further delays the diagnosis. The radiologist should be well versed with imaging findings of female genital TB to help the clinicians to initiate prompt treatment. This review shall cover imaging findings of female genital TB involving fallopian tubes, uterus, ovaries, cervix, vagina, and vulva on different imaging modalities. Fallopian tubes are almost always involved in genital TB followed by uterus and ovaries. Hysterosalpingogram and ultrasound can best detect tubercular changes in fallopian tubes and uterus whereas cross-sectional imaging is essential for the diagnosis of ovarian or peritoneal TB as they closely mimic malignancy. Cervical, vaginal, or vulval TB produces nonspecific changes and histopathological diagnosis is required for confirmation of the diagnoses. Close differential diagnosis on imaging like malignancy or pelvic inflammatory disease, are also discussed with a brief discussion of the pathogenesis., Competing Interests: Declaration of Competing Interest None., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.